Choose New Jersey-Sponsored East Asia Economic Mission Trip to Japan and South Korea, led by Governor Phil Murphy

Access BIO
2024-05-19 22:49
Access Bio Participates in Choose New Jersey-Sponsored East Asia Economic Mission Trip to Japan and South Korea, led by Governor Phil
  • Access Bio, is a New Jersey company located in Somerset, NJ since 2002
  • We plan to share the successful story of supplying diagnostic products to U.S. public institutions and contribute to helping Korean companies
    succeed in the global market.
Access Bio (CEO Young-ho Choi), a company specializing in in-vitro diagnostics, will take part in an economic mission trip to Japan and South
Korea, organized by Choose New Jersey and led by New Jersey Governor Phil Murphy.

The trip will span from October 14th to 22nd and will include an economic delegation of 30 to 40 people consisting of political, business, and
academic figures.

During the economic mission trip to East Asia, Access Bio plans to share its success stories and insights about New Jersey's business environment to leading Korean companies.

“As a Korean American businessman, I want to contribute to helping many Korean companies succeed in the global market, and I will be sharing
the know-how that I have gained through the past 20 years of business experience to participating Korean companies,” said Young-ho Choi, CEO of Access Bio. “It will be an honor to be here as one of the companies representing New Jersey.”

“We are excited to be joined by Access Bio’s CEO, Young-ho Choi, on our economic mission trip to East Asia,” said Governor Murphy. “With
headquarters in Somerset, I am grateful that Access Bio is able to help us represent New Jersey’s dedication to business and innovation. I look
forward to discussing their diagnostic work and finding ways to continue building upon our economic vision with the support of businesses abroad.”

Access Bio was established in Somerset, New Jersey, USA in 2002 and is a representative diagnostic company, ranking first in the world for malaria
rapid diagnostic kits (RDT). Additionally, during the COVID-19 pandemic, the company supplied more than 200 million self-diagnosis kits to the
U.S. federal government and major state governments. Recently, the company is expanding its business into the digital healthcare business
through strategic cooperation with Curapatient, an American digital healthcare company, and Wellysis, which owns a patch-type electrocardiogram
(US FDA 510(k)).

The East Asia economic mission will be attended by executives from leading global companies located in New Jersey, such as Johnson & Johnson
and Prudential Financial, as well as trade organizations and government officials.